Oppenheimer Reiterates an 'Outperform' on Accretive Health (AH); Believe in Ascension Deal
Tweet Send to a FriendGet Alerts AH Hot Sheet
Price: $10.93 -1.09%
Rating Summary:
4 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 8
Rating Summary:
4 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 8
Trade AH Now!
Oppenheimer reiterates an 'Outperform' on Accretive Health (NYSE: AH) price target of $17.00.
Analyst, Bret Jones, said, "Accretive Health filed a Form 8-K on Tuesday after the close that indicated it was in the process of a five-year renewal contract with its largest customer, Ascension Health. The renewal period was butting up against the 180-day notification period, so the two parties extended the notification period by 26 days...With the shares trading at 14x our and 18x consensus 2013 EPS estimates, we believe the market is pricing in additional customer losses. We continue to believe Ascension will renew by the end of the month and reiterate our rating."
For an analyst ratings summary and ratings history on Accretive Health click here. For more ratings news on Accretive Health click here.
Shares of Accretive Health closed at $11.24 yesterday, with a 52 week range of $7.75-$32.82.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Bret Jones, said, "Accretive Health filed a Form 8-K on Tuesday after the close that indicated it was in the process of a five-year renewal contract with its largest customer, Ascension Health. The renewal period was butting up against the 180-day notification period, so the two parties extended the notification period by 26 days...With the shares trading at 14x our and 18x consensus 2013 EPS estimates, we believe the market is pricing in additional customer losses. We continue to believe Ascension will renew by the end of the month and reiterate our rating."
For an analyst ratings summary and ratings history on Accretive Health click here. For more ratings news on Accretive Health click here.
Shares of Accretive Health closed at $11.24 yesterday, with a 52 week range of $7.75-$32.82.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- KeyBank Upgrades MDC Holdings (MDC); Cuts PulteGroup (PHM) & Ryland Group (RYL)
- Compuware (CPWR) Estimates Trimmed, PT Raised at Jefferies
- Leerink Swann Bullish on Insmed (INSM); Raises PT to $22
Create E-mail Alert Related Categories
Analyst Comments
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
